Girotec 25 Mg / 50 Mg / 100 Mg / 200 Mg Tablets 25 mg / 50 mg / 100 mg / 200 mg TABLETS
PDF Leaflet Revision Date: 09 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for epilepsy and bipolar disorder.
Dosage (summary)
Adults: Initial 25 mg daily, increase to 100-200 mg/day. Children: 0.6 mg/kg/day.
Onset of Action / Duration
Onset: 1.4 to 4.8 hours, Duration: 25 hours.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Enzyme inducers (e.g., phenytoin, carbamazepine) decrease levels
- Valproic acid increases levels
Contraindications
- Hypersensitivity to lamotrigine
- Renal and hepatic impairment
- Pregnancy
- Patients over 65 years
Common side effects
- Headache
- Dizziness
- Skin rash
- Nausea
- Drowsiness
Counselling Points
- Report any rash or flu-like symptoms immediately
- Avoid abrupt discontinuation
- Monitor weight in children for dose adjustments
Serious warnings
- Risk of serious skin reactions
- Monitor for hypersensitivity symptoms
- Risk of seizures upon abrupt withdrawal
Important Disclaimer
The Girotec 25 Mg / 50 Mg / 100 Mg / 200 Mg Tablets 25 mg / 50 mg / 100 mg / 200 mg TABLETS professional information leaflet below is the property of Aurobindo Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
